Viewing Study NCT02666261


Ignite Creation Date: 2025-12-24 @ 12:46 PM
Ignite Modification Date: 2026-02-07 @ 3:37 PM
Study NCT ID: NCT02666261
Status: COMPLETED
Last Update Posted: 2019-03-21
First Post: 2016-01-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ML29763
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators